Clinical Research Directory

Inclusion Criteria * Clinically confirmed diagnosis of bilateral spastic cerebral palsy. * Aged 6 to 16 years. * Classified as GMFCS Levels I-III. * Able to stand independently, with or without support. * Presence of clinically significant lower-limb spasticity, defined as Modified Ashworth Scale (MAS) score ≥2. * Demonstrated ambulatory ability with Timed Up and Go (TUG) ≤10 seconds. * Demonstrated walking ability with 6-Minute Walk Test (6MWT) distance of 50-500 meters at baseline. * Able to understand simple verbal commands and participate in structured therapy sessions. * Parent or legal guardian willing to provide written informed consent. * Willing and able to attend the complete 12-week intervention protocol. Exclusion Criteria * Botulinum toxin injection within the previous 6 months. * Recent pharmacological intervention significantly affecting spasticity. * Lower-limb orthopedic surgery within the previous 12 months. * Severe intellectual disability (IQ \<70) or inability to follow simple instructions required for therapy participation. * Uncontrolled seizures, epilepsy, or other neurological conditions that could interfere with participation. * Fixed musculoskeletal contractures limiting standing, stepping, or gait training. * Cardiopulmonary, medical, or orthopedic conditions that contraindicate treadmill-based exercise. * Current participation in another gait-training or rehabilitation research study.